In correlation with these, TAC tends to increase tumorigenic mTORC1/C2 activation and promotes proliferation in a cell-type dependent manner in epithelial and RCC cell lines, induced ischaemic kidneys, and RCC xenograft tumours as well. Here, C2 is linked to neoplasm.